miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer
Authors
Keywords
MicroRNA-101, EHZ2, Epithelial ovarian cancer, Disease progression, Cisplatin
Journal
TUMOR BIOLOGY
Volume 35, Issue 12, Pages 12619-12626
Publisher
Springer Nature
Online
2014-09-26
DOI
10.1007/s13277-014-2585-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
- (2013) Leibo Xu et al. JOURNAL OF HEPATOLOGY
- MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2
- (2011) Ji-guang Zhang et al. Journal of Thoracic Oncology
- Resistance, epigenetics and the cancer ecosystem
- (2011) Stephen B Baylin NATURE MEDICINE
- MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1
- (2011) Assaad Semaan et al. PHARMACEUTICAL RESEARCH
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
- (2010) Jianfeng Guo et al. CANCER SCIENCE
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-101-mediated Akt activation and estrogen-independent growth
- (2010) M Sachdeva et al. ONCOGENE
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2
- (2009) J. M. Friedman et al. CANCER RESEARCH
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- The roles of microRNA in cancer and apoptosis
- (2008) Niamh Lynam-Lennon et al. BIOLOGICAL REVIEWS
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
- (2008) Antonio Strillacci et al. EXPERIMENTAL CELL RESEARCH
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started